Afya (NASDAQ:AFYA – Get Free Report) announced its quarterly earnings data on Friday. The company reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.03, FiscalAI reports. Afya had a return on equity of 17.94% and a net margin of 20.20%.The firm had revenue of $187.80 million during the quarter, compared to analysts’ expectations of $189.62 million.
Afya Stock Up 3.2%
Shares of AFYA stock traded up $0.43 during midday trading on Friday, reaching $13.84. 168,637 shares of the stock were exchanged, compared to its average volume of 105,660. The firm has a market cap of $1.30 billion, a PE ratio of 9.05, a price-to-earnings-growth ratio of 1.45 and a beta of 0.34. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.42. Afya has a 1 year low of $13.00 and a 1 year high of $16.50. The company’s 50 day moving average is $14.27 and its two-hundred day moving average is $14.42.
Insider Buying and Selling
In other Afya news, VP Lelio De Souza Junior sold 36,204 shares of the stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $15.00, for a total transaction of $543,060.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, VP Gomiero Mirella Basolli sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $14.80, for a total transaction of $148,000.00. Following the completion of the transaction, the vice president directly owned 34,530 shares of the company’s stock, valued at approximately $511,044. The trade was a 22.46% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 87,745 shares of company stock valued at $1,314,175. Insiders own 0.80% of the company’s stock.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
Several brokerages have recently weighed in on AFYA. Wall Street Zen downgraded shares of Afya from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 2nd. Bank of America reiterated a “neutral” rating on shares of Afya in a research note on Thursday, June 11th. Weiss Ratings lowered shares of Afya from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, July 31st. Zacks Research downgraded Afya from a “strong-buy” rating to a “hold” rating in a report on Wednesday, May 6th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Afya from $21.50 to $21.00 and set a “neutral” rating for the company in a report on Monday, June 22nd. Six analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $18.00.
View Our Latest Analysis on Afya
Afya Company Profile
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
Read More
- Five stocks we like better than Afya
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
